Source: Revenio Group Oyj
Revenio Group Corporation Stock exchange release February 12, 2014 at 10.55 hrs.
THE BOARD'S PROPOSAL TO THE ANNUAL GENERAL MEETING
The consolidated net profit for the year totaled EUR 4,338 thousand and that of
the parent company EUR -304.972,66 The parent company's distributable earnings
on December 31, 2012 totaled EUR 8.372.815,50 The Board of Directors will
propose to the Annual General Meeting on March 21, 2014, that the parent
company's distributable earnings be allocated as follows:
- A per-share dividend of EUR 0.30, for a total of 2,355,143.70 against the
total number of shares on the balance sheet date, will be distributed. The rest
of the distributable retained earnings will be entered under equity. In the
Board's opinion, the proposed dividend distribution does not endanger the parent
company's or Group's liquidity.
Revenio Group Corporation
Board of Directors
For additional information:
President&CEO Olli-Pekka Salovaara,
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
The Revenio Group in brief
Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy. The widely patented Icare product family is the current cornerstone of the
Group's success. Revenio seeks vigorous growth in health technology, both
organically and through acquisitions and mergers.
The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.
In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its
operating margin standing at 21.7%. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.